Isomorphic Labs raises $2.1 billion in Series B funding
Led by Thrive Capital, with participation from Alphabet, GV, and new investors.
See the latest news and media coverage for Isomorphic Labs. We track all announcements, press releases, and industry mentions in real time, all in one place.
AI-driven drug discovery company
isomorphiclabs.comLast updated
In short: Isomorphic Labs raised $2.1B in Series B funding and unveiled its IsoDDE drug design engine.
Led by Thrive Capital, with participation from Alphabet, GV, and new investors.
The funding round is led by Thrive Capital with participation from GV and Alphabet to advance AI drug design and therapeutic programs.
The agreement adds up to three new research programs under the same financial terms as the original collaboration announced in January 2024.
The collaborations with Eli Lilly and Novartis could be worth nearly $3 billion and focus on multi-target small molecule research with upfront and milestone payments.
Google-backed Isomorphic Labs has secured $2.1 billion in Series B funding, turning an earlier plan to raise more than $2 billion into one of the...
Earlier this year, DeepMind spin-off Isomorphic Labs began preparing the first human clinical trials of drugs designed with its AI systems.
Isomorphic Labs raises $2.1B in Series B funding led by Thrive Capital to scale its AI-driven drug design engine and expand its global operations.
Google's head of AI, Demis Hassabis, will step down from his current role to become Alphabet's chief scientist amid a reshuffling at DeepMind that will...
Track Isomorphic Labs and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Isomorphic Labs and other trending companies.